The Mumbai-headquartered pharmaceutical company clarified the current status of the deal and said that the transaction is awaiting formal confirmation and a board resolution from Med Therapy’s board of directors.
Pharma stock under Rs 50 ends session in red, shares update on proposed acquisition of US-based firm
